Insider Trading July 7, 2026 06:34 PM

QuantumScape Executive Timothy Holme Offloads Nearly $1M in Stock Amid Solid-State Battery Push

CTO's divestment via pre-arranged trading plan coincides with recent earnings beat and strategic Honda partnership as the company advances its solid-state battery technology.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
QS

Timothy Holme, Chief Technology Officer at QuantumScape Corp (NASDAQ: QS), executed a significant divestment of company shares on July 2, 2026, totaling approximately $999,565. The transactions, conducted through both direct sales and indirect dispositions via The Holme 2020 Irrevocable Trust, were carried out under a Rule 10b5-1 trading plan established in June 2025. This financial activity occurs against a backdrop of recent corporate developments, including a first-quarter 2026 earnings performance that exceeded analyst expectations and a newly announced multi-year research collaboration with Honda R&D Co., Ltd. aimed at advancing solid-state battery manufacturing processes. The stock, currently trading at $6.79, has experienced significant volatility and depreciation over the past six months, reflecting the challenges inherent in the competitive electric vehicle component sector.

QuantumScape Executive Timothy Holme Offloads Nearly $1M in Stock Amid Solid-State Battery Push
QS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Timothy Holme liquidated nearly $1M in Class A Common Stock via direct sales and trust dispositions under a pre-arranged Rule 10b5-1 plan.
  • QuantumScape reported Q1 2026 EPS of -0.16, beating expectations by 11.11%, signaling potential operational stabilization in the EV component sector.
  • The company entered a multi-year joint research agreement with Honda R&D Co., Ltd., focusing on solid-state battery development and manufacturing.

Timothy Holme, serving as the Chief Technology Officer for QuantumScape Corp (NASDAQ: QS), finalized a series of stock disposals on July 2, 2026, resulting in the liquidation of Class A Common Stock valued at approximately $999,565. The execution of these sales occurred across multiple transactions, with share prices varying between $6.975 and $7.805. This divestment activity takes place while the company's equity is currently trading at $6.79, a figure that represents a substantial 38% decline over the preceding six-month period. Market analysis from InvestingPro indicates that the shares may be slightly overvalued when compared to fair value metrics. Furthermore, the stock is characterized by high volatility, evidenced by a beta of 2.62, which places it among the more volatile equities tracked in exclusive subscriber tips.

The specific mechanics of the transaction involved the direct disposition of 102,991 shares of Class A Common Stock by Mr. Holme. Concurrently, The Holme 2020 Irrevocable Trust facilitated the indirect disposal of an additional 34,254 shares of the same class. These sales were structured in compliance with a Rule 10b5-1 trading plan, a pre-arranged framework adopted by Mr. Holme on June 5, 2025, designed to manage insider trading activities within regulatory boundaries.

In a related development on the same date, Mr. Holme executed a conversion of 102,991 shares of Class B Common Stock directly into Class A Common Stock. The Holme 2020 Irrevocable Trust also participated in this conversion process, indirectly converting an additional 34,254 shares of Class B Common Stock into Class A Common Stock. The governing agreement for these share classes allows each share of Class B Common Stock to be converted into Class A Common Stock on a one-to-one basis at the reporting person’s election, with no expiration date attached to this conversion right.

Following the completion of these transactions, Mr. Holme's direct holdings in Class A Common Stock stand at 1,712,506 shares. This total includes 1,582,672 shares represented by restricted stock units ("RSUs") and performance restricted stock units ("PSUs"), which confer the right to receive one share of Class A Common Stock upon vesting. The Holme 2020 Irrevocable Trust no longer maintains any holdings in Class A Common Stock. Mr. Holme’s direct holdings of Class B Common Stock remain at 7,006,547 shares, with an additional 1,246,611 shares held indirectly through The Holme 2020 Irrevocable Trust.

QuantumScape's recent operational updates include the reporting of its first-quarter 2026 earnings, which surpassed analyst expectations. The company reported an earnings per share (EPS) of -0.16, outperforming the forecasted -0.18 by an 11.11% margin. This financial result suggests a degree of resilience in the company's cost management or revenue generation relative to market forecasts during this period.

Strategically, QuantumScape has announced a joint research agreement with Honda R&D Co., Ltd., a subsidiary of Honda Motor Co., Ltd. This multi-year collaboration is focused on the development and manufacturing processes of solid-state batteries. The agreement follows the completion of a technology evaluation agreement by Honda, which involved technical testing and competitive benchmarking of QuantumScape’s solid-state technology platform. These developments highlight the company's ongoing efforts to advance solid-state battery technology through strategic partnerships and improved financial performance metrics.

Risks

  • The stock has depreciated 38% over the past six months and exhibits high volatility with a beta of 2.62, indicating significant market risk for investors in the electric vehicle battery sector.
  • QuantumScape is still reporting negative earnings per share (-0.16), suggesting the company has not yet achieved profitability, which poses a fundamental risk to long-term valuation in the competitive battery technology market.
  • The reliance on strategic partnerships like the Honda collaboration for manufacturing processes introduces execution risk, as the success of solid-state battery commercialization remains dependent on external validation and technical scaling.

More from Insider Trading

Arista Networks Insider Sale: Bechtolsheim Offloads $39M Amid Strong Quarterly Results Jul 7, 2026 Ultra Clean Holdings Executive Offloads Shares Under Pre-Arranged Plan Jul 7, 2026 Immunome Director Isaac Barchas Executes $2.4M Share Sale Under Pre-Arranged Plan Jul 7, 2026 Shattuck Labs CTO Executes Pre-Arranged Stock Transactions Amid Capital Raise Jul 7, 2026 Voip-Pal CFO Executes $368 Stock Sale Amid Market Volatility Jul 7, 2026